Katherine A. High
2018
In 2018, Katherine A. High earned a total compensation of $2.3M as President and Head of Research and Development at Spark Therapeutics, a 8% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $233,179 |
|---|---|
| Option Awards | $1,086,725 |
| Salary | $471,039 |
| Stock Awards | $454,950 |
| Other | $39,058 |
| Total | $2,284,951 |
High received $1.1M in option awards, accounting for 48% of the total pay in 2018.
High also received $233.2K in non-equity incentive plan, $471K in salary, $455K in stock awards and $39.1K in other compensation.
Rankings
In 2018, Katherine A. High's compensation ranked 5,051st out of 14,244 executives tracked by ExecPay. In other words, High earned more than 64.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,051 out of 14,244 | 65th |
Division Manufacturing | 1,900 out of 5,765 | 67th |
Major group Chemicals And Allied Products | 696 out of 2,128 | 67th |
Industry group Drugs | 582 out of 1,817 | 68th |
Industry Biological Products, Except Diagnostic Substances | 118 out of 339 | 65th |
Pay ratio
| Katherine A. High's Pay | $2,284,951 |
|---|---|
| Median Employee's Pay | $182,200 |
| Pay Ratio | 13to 1 |
In 2018, the annual total compensation of Katherine A. High was $2,284,951.
The annual total compensation of the median employee at Spark Therapeutics was $182,200.
The ratio of Katherine A. High's pay to the pay of median employee was therefore 13 to one.
Source: SEC filing on July 22, 2019.
High's colleagues
We found four more compensation records of executives who worked with Katherine A. High at Spark Therapeutics in 2018.